---
schema_version: "secwatch.filing_event.v1"
accession: "0000917520-25-000052"
form_type: "8-K"
ticker: "IART"
cik: "0000917520"
company_name: "INTEGRA LIFESCIENCES HOLDINGS CORP"
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T19:58:29.630851+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Integra LifeSciences shareholders approve 2.2M share increase in equity plan; chairman transitions to non-executive role

## Summary
- Stockholders approved Amendment No. 2 to increase shares under equity plan by 2.2M, to 20.7M total.
- All nine director nominees elected at May 9 annual meeting; PwC ratified as auditor; say-on-pay approved.
- Board approved transition of Dr. Essig from Executive Chairman to non-executive Chairman effective July 1, 2025; no disagreement.
- Plan amendment eliminates provision allowing shares withheld for taxes to be returned to the plan.

## SEC filing metadata
- accession: 0000917520-25-000052
- form_type: 8-K
- ticker: IART
- cik: 0000917520
- company_name: INTEGRA LIFESCIENCES HOLDINGS CORP
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/917520/000091752025000052/0000917520-25-000052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/917520/000091752025000052/iart-20250509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000917520-25-000052
- JSON: https://secwatch.observer/filing/0000917520-25-000052.json
- Plain text: https://secwatch.observer/filing/0000917520-25-000052.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.